CpG oligodeoxynucleotide GNKG168

Definition / meaning of CpG oligodeoxynucleotide GNKG168

A synthetic, 21-mer, unmethylated CpG motif-based oligodeoxynucleotide (ODN), with immunostimulatory activity. CpG oligodeoxynucleotide GNKG168 binds to and activates Toll-like receptor 9 (TLR9) and is taken up into cells by endocytosis; once internalized, it may activate numerous signaling transduction pathways resulting in the release of multiple cytokines, such as immunoglobulins (Igs), interferons (IFNs), interleukins (ILs) and tumor necrosis factor (TNF). Through activation of TLR9, this ODN can directly stimulate B-lymphocytes, dendritic and natural killer (NK) cells, resulting in an increase in innate immunity and antibody-dependent cellular cytotoxicity (ADCC). In addition, through the release of IL-12 and IFN, this agent may induce a preferential shift to the T-helper 1(Th1) phenotype resulting in enhanced CD8+ T cell-mediated antitumor cytotoxicity.

Listed under:

Find More About 'CpG oligodeoxynucleotide GNKG168'

Source(s):

The Web site of the National Cancer Institute (http://www.cancer.gov/drug)

Leave a Comment

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.